CoMBAT Opioid Use Disorder: A Combined Medication and Behavioral Activation Treatment for People Living With Opioid Use Disorder

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

February 18, 2022

Study Completion Date

March 31, 2022

Conditions
Opioid-use DisorderMedication AdherenceHealth Care Utilization
Interventions
BEHAVIORAL

Behavioral Activation (BA) Therapy

8 sessions of behavioral activation therapy

BEHAVIORAL

Substance Abuse and Health Navigation Counseling

2 standard substance abuse and health navigation counseling

OTHER

Medications for Opioid Use Disorder

Medications for opioid use disorder (i.e., buprenorphine and methadone) as prescribed by a community provider (not provided as part of the study).

Trial Locations (1)

02912

Brown University, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Boston University

OTHER

collaborator

University of Massachusetts, Boston

OTHER

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

collaborator

Rhode Island Hospital

OTHER

lead

Brown University

OTHER